Ontology highlight
ABSTRACT: Background
Regardless of the efforts to ease cases of human African trypanosomiasis (HAT), an increased number of cases get reported annually. This is because of drug resistant Trypanosoma brucei (Tb), the causative agent of the illness. This has renewed the need for creative methods to find new anti-trypanosomal drugs. The blood stream form (BSF) of the parasite depends exclusively on the glycolytic pathway for energy production while it is in the human host. Interruptions in this pathway efficiently kills the parasite. Trypanosoma brucei hexokinase (TbHK) is the first enzyme in glycolysis, and any effectors or inhibitors of TbHK would have potential as anti-trypanosomal agents.Methods
TbHK and human glucokinase (hGCK) were over-ex
SUBMITTER: Mlozen MM
PROVIDER: S-EPMC10041994 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature